Skip to main content

Peer Review reports

From: A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib

Original Submission
5 Aug 2021 Submitted Original manuscript
23 Aug 2021 Author responded Author comments - Yan Chen
Resubmission - Version 2
23 Aug 2021 Submitted Manuscript version 2
7 Feb 2022 Reviewed Reviewer Report
2 Mar 2022 Reviewed Reviewer Report
27 Mar 2022 Author responded Author comments - Yan Chen
Resubmission - Version 3
27 Mar 2022 Submitted Manuscript version 3
12 Apr 2022 Reviewed Reviewer Report
25 Apr 2022 Reviewed Reviewer Report
26 Apr 2022 Reviewed Reviewer Report
5 May 2022 Author responded Author comments - Yan Chen
Resubmission - Version 4
5 May 2022 Submitted Manuscript version 4
6 May 2022 Reviewed Reviewer Report
6 May 2022 Reviewed Reviewer Report
16 May 2022 Author responded Author comments - Yan Chen
Resubmission - Version 5
16 May 2022 Submitted Manuscript version 5
25 May 2022 Author responded Author comments - Yan Chen
Resubmission - Version 6
25 May 2022 Submitted Manuscript version 6
2 Jun 2022 Author responded Author comments - Yan Chen
Resubmission - Version 7
2 Jun 2022 Submitted Manuscript version 7
10 Jun 2022 Author responded Author comments - Yan Chen
Resubmission - Version 8
10 Jun 2022 Submitted Manuscript version 8
Publishing
15 Jun 2022 Editorially accepted
23 Jun 2022 Article published 10.1186/s12920-022-01291-z

You can find further information about peer review here.

Back to article page